NCT05213195 2024-02-12
NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer
Zhejiang University
Phase 1 Unknown
Clinical Trials
4 trialsNCT04650451 2023-04-20
Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors
Bellicum Pharmaceuticals
Phase 1 Suspended
NCT05248048 2022-02-21
NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer
The Third Affiliated Hospital of Guangzhou Medical University
Phase EARLY_PHASE1 Unknown
NCT01583686 2019-10-14
CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated